| Predicted Trait | |
| Reported Trait | Inflammatory bowel disease | 
| Mapped Trait(s) | inflammatory bowel disease (EFO_0003767) | 
| Score Construction | |
| PGS Name | GPS_IBD | 
| Development Method | |
| Name | LDpred | 
| Parameters | ρ = 0.1; LD panel = 503 1000G Europeans | 
| Variants | |
| Original Genome Build | hg19 | 
| Number of Variants | 6,907,112 | 
| Effect Weight Type | NR | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000006 | 
| Citation (link to publication) | Khera AV et al. Nat Genet (2018) | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | 
|---|---|---|---|
GWAS Catalog: GCST003043 Europe PMC: 26192919  | 
                        
                            34,652 individuals | European | NR | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| — | [ 
  | 
                        
                            European | UKB | Inflammatory bowel disease ascertainment was based on report in an interview with a trained nurse, or an ICD-9 code of 555.X or ICD-10 code of K51.X in hospitalization records. | — | — | — | UKB Phase 1 | 
| 
                          PGS Performance Metric ID (PPM)  | 
                    
                        
                          PGS Sample Set ID (PSS)  | 
                    
                        Performance Source | Trait | 
                          PGS Effect Sizes (per SD change)  | 
                    
                        Classification Metrics | Other Metrics | Covariates Included in the Model | 
                          PGS Performance: Other Relevant Information  | 
                    
                    
|---|---|---|---|---|---|---|---|---|
| PPM000026 | PSS000016| European Ancestry| 288,978 individuals  | 
                        
                            PGP000006 | Khera AV et al. Nat Genet (2018)  | 
                        
                            Reported Trait: Inflammatory bowel disease | — | AUROC: 0.63 [0.62, 0.64] | Nagelkerke’s R2 (estimate of variance explained by the PGS after covariate adjustment): 0.021 | age; sex; Ancestry PC 1-4; genotyping chip | — | 
| PPM012874 | PSS009588| European Ancestry| 1,433 individuals  | 
                        
                            PGP000288 | Garcia-Etxebarria K et al. Sci Rep (2022) |Ext. | 
                        
                            Reported Trait: Inflammatory Bowel Disease | — | AUROC: 0.69 [0.66, 0.72] | — | — | — | 
| 
                          PGS Sample Set ID (PSS)  | 
                    
                        Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS009588 | — | — | [ 
  | 
                        
                            — | European | — | BV | — | 
| PSS000016 | Inflammatory bowel disease ascertainment was based on report in an interview with a trained nurse, or an ICD-9 code of 555.X or ICD-10 code of K51.X in hospitalization records. | — | [ 
  | 
                        
                            — | European | — | UKB | UKB Phase 2 |